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Studies have shown that depression is very common amongst coronary artery disease 
(CAD) patients. It is believed to be a major independent risk factor for CAD as well a poor 
prognostic factor and is associated with reduced quality of life (QOL). Post-infarction 
inflammatory and neurohormonal changes are postulated to link CAD to the development 
of depression. Patients undergoing CABG and PCI patients differ greatly in terms of injury 
severity score, metabolic and inflammatory response, as such theoretically the prevalence 
of depression and response to lifestyle modification (LSM) is expected to differ between 
the two groups. It is not known to what extent the mode of revascularization [coronary 
artery bypass graft (CABG) vs percutaneous intervention (PCI)] influences the prevalence 
and severity of depression.  However, most of the studies on this topic have been 
performed in developed countries, where patents have easy access to care and 
rehabilitation after myocardial infarction (MI). Since little data exists in developing 
countries on the relationship between depression and CAD, we studied the prevalence of 
depression in subjects with MI undergoing revascularisation at Inkosi Albert Luthuli Central 
Hospital (IALCH) and analysed how LSM affects that. 
In this study we evaluated the risk factor profile, depression characteristics and changes in 
lifestyle in 100 consecutive participants undergoing coronary revascularization over a 15-
month period (Jan 2017- March 2018). The Beck Depression Inventory II (GDI-II) was used 
to assess depression and the Goldin leisure-time exercise (GLTE) questionnaire to assess 
the physical activity (PA) component of lifestyle modification. 
The prevalence of depression and depression traits among subjects immediately after 
coronary revascularization was 51%. After LSM the incidence of depression fell from 51.0% 
to 34.7% (P=0.022), with fewer PCI subjects having depression and depression traits 
compared to CABG {PCI 8 (23.0%) vs CABG 25 patients (72.0%), p= 0.000}.  The mean 
depression scores also fell from 21.91±7.75 prior to LSM to 14.98±9.61 (p=0.002), with a 
greater point score reduction in the PCI compared to CABG group (7.90 vs 4.30), (p=0.000) 
respectively.  In addition, we found the prevalence of depression and depression traits to 
be significantly lower amongst LSM-compliant subjects post LSM (1 person), compared to 
32 subjects in partly-compliant subjects (p=0.001). Further analysis revealed that the 
participants who were fully compliant in both CABG vs PCI  groups derived similar benefits 
in terms of reduction in prevalence of depression and depression severity, (P=0.191). The 





CABG (OR 1.86, 95% CI 1.68-5.77,  p = 0.003), heart failure (OR 2.65, 95% CI 5.87-13.62,     
p = 0.000), Kidney failure (OR 1.41, 95% CI 1.30-5.23, P = 0.041), atrial fibrillation (OR 1.60, 
95% CI 1.40-4.77, P = 0.023), low PA (OR 1.97, 95%, CI 11.23-3.20, P = 0.000), previous 
history of depression (OR 8.99,95% CI 1.90-7.89, p = 0.002) and low income (OR 2.21, 95% 
CI 1.40-2.85,  p = 0.000). 
In this study we found that depression and depression traits are common in subjects who 
had sustained MI and undergone revascularisation, but commoner among CABG patients. 
The participants in the PCI group derived greater benefit from lifestyle intervention than 
the CABG group probably related to early ambulation after PCI. After LSM, depression and 
depression traits were significantly less common amongst LSM-compliant subjects, 
regardless of the mode of revascularisation. Furthermore, failure to implement changes in 
PA after revascularisation was a major barrier to managing depression after coronary 
revascularisation. Other aspects of LSM like cigarette smoking cessation and dietary 
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CHAPTER 1: Literature Review 
 
I. Introduction 
The prevalence of non-communicable diseases of lifestyle is increasing in developing 
countries, including South Africa. [1-5]  This has resulted in worsening mortality, morbidity 
and adverse psychosocial outcomes amongst coronary artery disease (CAD) patients in 
contrast to developed countries where modern therapies and lifestyle modification (LSM) 
has been shown to reduce morbidity, mortality and effectively manage psychosocial 
adverse outcomes. [6-14] 
Epidemiological and observational studies have reported a high prevalence of depression 
amongst CAD. [15-20]    It is established that patients with depression are more prone to 
developing CAD and that CAD patients have an increased risk of depression. [15-20]    This 
identifies depression as an independent risk factor for CAD as well a poor prognostic 
factor.[21-23]   Coronary artery disease patients with depression have been observed to 
have worse adverse cardiac outcomes and reduced quality of life (QOL). [21-23]   The 
Baltimore cohort of the Epidemiologic Catchments Area study follow-up revealed that 
major depression significantly increased the risk of acute myocardial infarction (OR 4.54, 
95% CI 1.65-12.44). [24]   A systemic review by the American Heart Association also found 
that depressed myocardial infarction patients had a significant increase in all-cause 
mortality, cardiac mortality and chances for recurrence, compared to non-depressed 
patients. [25] 
Although the incidence of CAD is increasing globally, morbidity and mortality are steadily 
decreasing in the developed countries [3-9].   This has been attributed principally to better 
therapy and LSM which has shown promising results in the secondary prevention of CAD, 
reducing adverse cardiac outcomes and depression, as well as improvement in the QOL. 
[9-14]   In contrast to the developed world there is little data from the developing 
countries regarding the prevalence of depression and the effect of lifestyle changes on 
depression amongst patients with CAD. [12-16]   However, even in the developed 
countries, to the best of our knowledge no study has examined the effect of LSM on 
depression amongst patients who undergo coronary artery bypass graft surgery (CABG) vs 
percutaneous coronary intervention (PCI). These two modalities of therapy differ greatly in 
terms of injury severity score, convalescence, metabolic and inflammatory responses.    





post-infarction inflammatory and neurohormonal changes [28-34],  thus we hypothesized 
that the prevalence of depression and response to LSM would differ between CABG and 
PCI groups. In this study we analysed the prevalence of depression amongst MI patients 
after revascularisation and examined the effect of LSM on incidence of depression 
between CABG vs PCI groups.  
We evaluated the risk factor profile, depression characteristics and lifestyle changes of 100 
consecutive participants undergoing coronary revascularization over a 15-month period 
(Jan 2017 to March 2018). The Beck Depression Inventory II (BDI-II) was used to assess 
depression and the Goldin leisure-time exercise questionnaire (GLTEQ) to assess physical 
activity (PA).   
 
II). Prevalence of depression  
Numerous studies have reported that depression is very common amongst CAD patients 
with prevalence varying from 10% to 65% [15-19].    In contrast to the developed countries 
there is little data from the developing nations regarding the prevalence of depression 
amongst CAD patients. [3-5]   In a recent study, Ranjith et al analysed depression in 
patients with myocardial infarction (MI) in South Africa and reported a prevalence of 49% 
[20].    To the best of our knowledge no study has investigated the effects of LSM and 
revascularisation procedures on depression amongst CAD patients in Africa. 
 In a prospective study Gu G, et al investigated the incidence of depression amongst 
patients with CAD before and after PCI in China. They randomly selected one hundred and 
seventy (170) CAD patients who underwent PCI between September 2013 and February 
2014. The patients completed the Hospital Anxiety and Depression Scale (HADS) and a 
preoperative questionnaire one day before PCI and the same questionnaire was re-
administered a day after the procedure, and at one, three, six, and twelve months later. 
They showed that PCI was significantly associated with the symptoms of anxiety and 
depression (p < 0.01) at each follow-up time point. They concluded that the incidence of 
anxiety and depression significantly increases the day before and the day after PCI 
procedure, and thereafter decreased with time. The predictors of anxiety and depression 
in their study were a low level of education, apprehension regarding quality of nursing 





Amongst the studies that analyzed incidence of depression after acute coronary syndrome 
(ACS), the “Depression after First Hospital Admission for Acute Coronary Syndrome: A 
Study of Time of Onset and Impact on Survival” was prominent. It was conducted at 
Research Center for Prevention and Health, Copenhagen University, by Osler M et al. They 
examined incidence of depression after ACS and assessed whether the timing of onset of 
depression influenced long term survival. The ACS patients (cases) were identified through 
the National Patient Register, and a comparable reference population sample (control) 
was matched on 1:1 basis. Both samples were followed for depression and mortality 
outcomes from the beginning of the study until the end of follow-up (2 years for 
depression and 12 years for mortality). The results showed that 19,520 (20.0%) out 97,793 
ACS patients recruited developed depression within 2 years of follow up, while in the 
reference population 14,386 persons (14.7%) developed depression. Higher rates of 
depression were seen in single persons, people with a basic education, and people with 
previous depression or other disease comorbidity.  Although the depression rate was 
higher in women than men this finding was not significant. At the end of 12 years follow-
up, 39,523 (40.4%) ACS patients and 27,931 (28.6%) members of the reference population 
died. Mortality rate was higher amongst depressed patients compared to those without 
depression in both the ACS patients and the reference population. This study concluded 
that depression is common in ACS patients and it is associated with increased mortality 
independent of its time of onset. [36] 
 
III). Pathogenetic mechanisms linking CAD to depression 
Several underlying pathophysiological changes are postulated to link CAD to the 
development of depression. One aspect that has been studied is heart rate variability 
(HRV) as a method of assessing cardiac autonomic function and a measure of allostatic 
load (dysfunction of autonomic system homeostasis over time as a result of chronic 
exposure to stress) after myocardial injury. [32-34]   Reduced heart rate variability (HRV) is 
manifestation of sympathetic hyperactivity and reduced parasympathetic activity (vagal 
tone) and has consistently been shown to be associated with depression. It is believed to 
be caused by autonomic system and hypothalamic–pituitary–adrenal (HPA) axis 
dysregulation that occurred after myocardial infarction. [32-34]   Although the exact 
mechanism is not known it is possible that the magnitude of myocardial injury may be 





Studies have shown a causal relationship between depression and post-infarction 
inflammatory and neurohormonal changes. Numerous inflammatory markers have been 
found in patients with CAD e.g. C-Reactive Protein (CRP), Interleukin 6 and soluble 
intercellular adhesion molecules. The surge in the inflammatory markers significantly 
influences the neurohormonal milieu and HPA axis, manifesting physically as mental and 
psychological changes of depression and anxiety. [28-32]   In view of this, we hypothesize 
that patient who undergo CABG are likely to be more depressed compared to PCI subjects, 
because the patients selected for CABG surgery generally have more severe and extensive 
coronary artery disease (triple vessel disease or left main coronary artery involvement)  
and are expected to generate a greater  inflammatory response compared to milder 
disease (single or double vessel disease ) in the majority of patients undergoing PCI. 
 
V). Lifestyle modification program and its effect on depression 
Lifestyle modification (LSM) is the main component of cardiac rehabilitation (CR) program. 
The American heart association (AHA), Australian Cardiovascular Health and Rehabilitation 
Association (ACRA), European Society of Cardiology (ESC), and many other international 
health bodies consistently recommend LSM as an important integral part of 
comprehensive care to patients with cardiovascular disease. [37-39]    It comprises a 
customized program of exercise, health education and behavioral changes that aimed to 
help CAD patients recover from heart disease and live a normal or near normal life, largely 
through their own effort. It involves a structured training program of aerobic exercises and 
health education, ranging from healthy eating patterns, stress management, and cigarette 
smoking cessation [37-39,40]  The European Guidelines on Cardiovascular Disease 
Prevention in Clinical practice (2016 version) [39], included the following as components of 
CR programs:   
1) Cognitive behavioural strategies to lifestyle changes including cigarette smoking 
cessation 
2) Professional nutritional counseling (<5 g of salt per day, 200 g of fruit per day (2–3 
servings), 200 g of vegetables per day (2–3 servings), fish at least twice a week) 
3) Long term individual exercise and physical activity (PA) 





Several studies have highlighted the beneficial effect of LSM in improving depressive 
symptoms amongst CAD patients [41-45].    A study conducted in the United states of 
America (USA) by Carl JL, et al, examined the effect of LSM program on exercise capacity, 
CAD risk factors, behavioural characteristics, and QOL in young and elderly patients. It was 
found that LSM improved depression, anxiety and other psychological risk factors with 
fewer adverse clinical events occurring amongst both groups. The study also showed 
significant benefits in terms of exercise capacity, QOL and reduction in CAD risk factors. 
They concluded that LSM is beneficial in both the elderly and in young adults, and leads to 
modest improvement in lipids, obesity indexes, behavioural characteristics, as well as 
marked improvement in exercise capacity. They emphasized that elderly patients had 
greater improvements than younger patients in both exercise capacity and mental health. 
[46] 
In addition to improvement in psychosocial functioning, LSM is believed to enhance quick 
recovery, and to decrease morbidity and mortality as well as increase QOL. [47-54]    The 
Lifestyle Heart Trial was amongst the pioneer studies that investigated the effect of 
lifestyle changes on CAD. It was a randomized controlled trial (RCT) that compared the 
effect of LSM amongst the experiment group (the LSM group) and control groups (those 
on regular CAD treatment only). The study demonstrated that LSM leads to significant 
reduction in CAD risk factors, reduction in risk of subsequent fatal MI, and generalized 
improvement in QOL. Baseline comparison of experimental and control group showed no 
significant differences in terms of demographic and clinical characteristics.  At the end of 
the first year of the study, LDL cholesterol decreased by 40% and remained 20% below 
baseline at 5 years amongst experimental group even though they were not on anti-lipid 
medications. In the control group, LDL cholesterol levels decreased by 1.2% at 1 year and 
by 19.3% at 5 years (P= 0.007). High density lipoprotein, triglycerides and blood pressure 
did not differ significantly between the 2 groups at the end of the trial. Weight loss was 
higher among the experimental group (10.9 kg)) at 1 year and 5.8 kg at 5 years, while 
there was negligible change in weight in the control group at the end of the trial (P= 
<0.000). Experimental group patients had a 91% reduction in reported frequency of angina 
after 1 year and a 72% reduction after 5 years, while the control group patients had an 
186% increase in reported frequency of angina after 1 year and a 36% decrease in 
frequency of angina after 5 years (P= 0.058). At 5 years, secondary MI was much higher in 





events per patient), and the control group patients were more likely to have fatal MI than 
experimental group patients. [55] 
The tremendous improvement gained from LSM has been attributed to reduction in 
modifiable cardiac risk factors, and rebuilding the patient's life physiologically, physically 
and psychologically. [41-45, 46, 47-54, 55]     Despite its documented benefits, most CAD 
patients are not referred to LSM program centres in the developed countries, whilst in the 
developing countries the LSM programs services are rarely available. [56-59]     Even 
among the recruited patients, LSM compliance is poor with only about 33% compliance 
after 6 months of initiating LSM. [60-61]     Of concern is the report that benefits gained 
from LSM are proportional to the duration of attendance, with possibly reversal of the 
benefits after discontinuation of the program. [62]  
 
 Motivation for the study 
The aforementioned studies have shown that depression is common in subjects with CAD 
and that both depression and its adverse outcomes are amenable to LSM program. 
Coronary artery disease is an emerging disease in the third world countries such as South 
Africa where the epidemiological transition to a westernised lifestyle is currently 
progressing on course.[5-6]    However, unlike developed nations, there is a scarcity of 
information regarding the prevalence of depression amongst CAD and effect of LSM on the 
depression. There is probably also a widespread underestimation of depression in this 
population. One local study has reported a high prevalence of depression amongst 
patients with myocardial infarction (MI) in South Africa, [16]   but no study has examined 
the influence of the mode of revascularisation and LSM on the incidence of depression 
following MI. The combination of depression and CAD is of great socioeconomic 
importance given that these two conditions are amongst leading causes of global health 
burden.  
This study will provide information on prevalence of depression after revascularization and 
will investigate the role of LSM in managing depressed CAD patients. Information 
generated from the study might also shed light on the effectiveness of LSM in managing 
depressed CAD patients. This is of importance to clinicians and policy makers in 
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CHAPTER 2: Manuscript 
 
The effect of lifestyle modification on depression amongst myocardial 
infarction patients after revascularization 
 
ABSTRACT 
Background: Patients with Coronary Artery Disease (CAD) are prone to depression, and its 
presence is associated with poor adverse cardiac outcomes. Although lifestyle 
modification (LSM) has been shown to be beneficial in managing depression in patients 
with CAD, it is not known whether the mode of cardiac intervention (coronary artery 
bypass graft surgery {CABG} vs percutaneous coronary intervention {PCI}) influences the 
outcome 
Objectives: We examined the prevalence of depression and depression traits amongst 
myocardial infarction (MI) patients after revascularisation and compared the effect of LSM 
on incidence of depression and depression traits in patients who underwent CABG versus 
PCI  
Method: We evaluated the risk factor profile, depression characteristics and lifestyle 
changes of 100 consecutive participants undergoing coronary revascularization over a    
15-month period (Jan 2017 to March 2018). The Beck Depression Inventory II (BDI-II) was 
used to assess depression and the Goldin leisure-time exercise (GLTE) questionnaire to 
assess physical activity (PA).   
Results: 100 patients were recruited (mean age males 60.73±4.52 yr and females 
60.29±3.64 yr), with 5 dropouts leaving 95 patients for complete analysis. Most of the 
patients were low-income earners 53 (53.0%) and 21.0% had tertiary level education. The 
majority had multiple CAD risk factors and comorbidities (79.0%). Prior to the LSM 
program 51 patients (51.0%) had depression and depression traits {CABG 34 (66.7%) vs PCI 
17 (33.3%), p = 0.047)}. After LSM the overall prevalence of depression and depression 
traits fell to 33 patients (34.7%), {PCI 8 (23.0%) vs CABG 25 patients (72.0%), p = 0.001}.  
The mean depression scores also fell from 21.11±7.75 to 14.98±9.61 (p = 0.002).  At 
baseline PCI patients were more physically active compared to CABG {3 (60.0%) vs 2 
patients (40.0%), P = 0.715} respectively. After the LSM, more PCI patients undertook PA 





score was also higher amongst the PCI group compared to CABG {14.16±9.73 vs 
9.40±10.94 respectively, p = 0.024}. In fully compliant subjects the benefit derived was 
similar regardless of the mode of intervention {OR 1.10, CI 0.98-4.23,P = 0.191}.  Using 
multivariate analysis the main predictors of depression and depression traits were female 
gender (OR 3.29, 95% CI 1.51-11.03, p = 0.008), CABG (OR 1.86, 95% CI 1.68-5.77,                
p = 0.003), heart failure (OR 2.65, 95% CI 5.87-13.62, p = 0.000), Kidney failure (OR 1.41, 
95% CI 1.30-5.23, P = 0.041), atrial fibrillation (OR 1.60, 95% CI 1.40-4.77, P = 0.023), low 
PA (OR 1.97, 95%, CI 11.23- 33.20, P = 0.000), previous history of depression (OR 8.99,95% 
CI 1.90-7.89, p = 0.002) and low income (OR 2.21, 95% CI 1.40-2.85,   p = 0.000). 
Conclusions: Depression  and depression traits are common among subjects undergoing 
coronary revascularization, more so amongst CABG compared to PCI participants. Lifestyle 
modification reduces  the prevalence of depression and depression traits, with fully 
compliant CABG vs PCI groups deriving nearly the same benefits from the LSM regime.  No 
significant reduction in depression and depression was recorded amongst LSM partly-
compliant patients.  This study suggests that failure to implement lifestyle changes and 
engage in PA are major barriers to managing depression after coronary revascularisation. 
Keywords: Depression, Coronary Artery Disease, Coronary artery bypass graft surgery, 
percutaneous coronary intervention, Lifestyle modification, Beck depression inventory-II, 
Goldin leisure time-exercise questionnaire 
 
 Introduction 
Several studies have shown that depression is very common amongst CAD patients with a 
prevalence varying from 10.0% to 65.0% [1-7].   Depression is thought to be a risk factor 
for CAD as well a poor prognostic factor. [8-12]. Patients with CAD who have depression 
have been shown to have worse adverse outcomes and reduced quality of life (QOL).        
[4, 6-7]   It is well established that CAD with depression has higher chances for MI 
recurrence and increased risk of death. [13-18]   In the Baltimore cohort of the 
Epidemiologic Catchments Area study follow-up, major depression significantly increased 
the risk of acute myocardial infarction (OR 4.54, 95% CI 1.651-12.440). [19]   A systemic 
review by the American Heart Association also found that depressed myocardial infarction 
patients had a significant increase in all-cause mortality, cardiac mortality and chances for 





increasing globally, morbidity and mortality are steadily decreasing in the developed 
countries [20-23]   and this has been attributed principally to better therapy as well as LSM 
which has shown promising results in the secondary prevention of CAD, reducing adverse 
cardiac outcomes and depression, as well as  improving QOL. [24-28]    In contrast to the 
developed world there is little data from the developing countries regarding the 
prevalence of depression and the effect of lifestyle changes on depression among patients 
with CAD. [21-23]   In a recent study Ranjith et al analysed depression amongst myocardial 
infarction (MI) patients in South Africa and reported a prevalence of 49.0% [29].   
To the best of our knowledge, no study has compared the effects of LSM on depression 
amongst patients who undergo Coronary artery bypass graft surgery (CABG) versus 
percutaneous coronary intervention (PCI). These two modalities of therapy differ greatly in 
terms of injury severity score, metabolic responses, convalescence and prognosis. [30-31]    
Furthermore studies have shown a causal relationship between depression and post-
infarction inflammatory and neurohormonal changes [32-38].   Thus, we hypothesized that 
the prevalence of depression and response to LSM would differ between the two groups. 
In this study we analysed the prevalence of depression amongst MI patients after 
revascularisation and examined the effect of LSM on incidence of depression between 




The risk factor profile, depression characteristics and physical activity (PA) profile were 
prospectively examined in 100 consecutive participants undergoing coronary 
revascularization over a 15-month period (Jan 2017 to March 2018). The study was 
conducted in the Department of Cardiology and Cardiothoracic surgery at Inkosi Albert 
Luthuli Central Hospital (IALCH), Durban, South Africa. After informed written consent was 
obtained, patients who met the inclusion criteria were enrolled within two (2) to four (4) 
weeks after revascularisation.  
The demographic, anthropometric measurements, vital signs and other clinical data, as 
well as blood samples, were obtained from the patients at the beginning of the study and 






Questionnaire administration  
During the interview, the Beck depression inventory-II (BDI- II) and Goldin Leisure-Time 
Exercise (GLTE) questionnaires were administered by the researcher (AA) to determine 
depression status and level of PA.  The GLTE questionnaire is a validated and reliable 
questionnaire that is used to assess the level of PA. [39]    Briefly, the patients indicate the 
number of times they engage in mild, moderate or strenuous exercise for more than 15 
minutes within a week. The level of PA is categorised as: ‘sufficiently active’ (≥24 
units/week), ‘moderately active’ (14-23 units/week), and ‘insufficiently active’ (<14 
units/week). [39]    For strenuous PA, the GLTE questionnaire  demonstrated moderate to 
strong associations with measured indices of PA particularly maximal oxygen consumption 
determinations (VO2max), and percent body fat by hydrostatic weighing (% BF), but a 
lesser degree of association with the Caltrac accelerometer (CALTRAC) readings.  For 
moderate PA, it was modestly correlated with the above measures, but for mild PA it 
showed less association with these measures. By and large it gives a reliable and fairly 
accurate assessment of PA. [40] 
The Beck Depression Inventory-II (BDI-II) is a 21-item, simple, reliable, and validated 
questionnaire, rated on a four-point scale (0-3). [41]     It is one of the most widely used 
psychometric instrument in both research and clinical practice for assessing depression. 
[42]     Based on the total score obtained, a patient is classified as normal (1-10), mild 
mood disturbance (11-16), borderline depression (17-20) moderate depression (21-30), 
severe depression over (31-40) and extreme depression (>40). [41]   The BDI-II adequately 
corresponds to diagnostic and statistical manual of mental disorders (DSM-IV) criteria and 
has high reliability and validity. Based on available psychometric evidence, the BDI-II is 
considered as a cost-effective questionnaire for measuring the severity of depression, with 
broad applicability for research and clinical practice worldwide. Although the 
questionnaire was originally designed to measure the severity of depression, existing 
evidence shows that the BDI-II can be effectively used to screen for major depression with 
a sensitivity of more than 70%. Its major shortcoming is variability of the cut-off score to 
screen for depression according to the type of sample. Non-clinical samples displayed the 
lowest range of cut-off points (from 10 to 16) to detect major depression, medical samples 
had an intermediate cut-off (from 7 to 20), and psychiatric samples had the highest cut-off 
(from 19 to 31). As a self-report measure there may be reporting bias since the 





Cardiac rehabilitation, recruitment and follow up 
Eligible patients were enrolled in a supervised exercise based LSM program and after a few 
sessions, an individualised aerobic exercise regimen was prescribed based on the standard 
guidelines. [43-45] Psychological counselling, smoking cessation and dietary advice were 
given as well. At the time of discharge, a referral letter and written instructions about the 
individualised LSM were given to the patients and they were advised to continue the 
program at home. The written instructions included how to monitor the level of exertion 
manually using their heart rate and the Borg’s rating of physical exertion at home. Studies 
have shown that homebased LSM is safe and not inferior to centre-based LSM. [46-48]     
Patients continued the LSM at home with a monthly follow-up at their community clinics. 
After a 12 weeks period, the patients underwent a final assessment by the researcher 
(AA). At the final visit, anthropometric measurement, vital signs, blood samples and 
clinical evaluation were repeated and documented. The BDI-II and GLTE Questionnaires 
were re-administered, and the results documented. 
Inclusion criteria  
Male or female eligible adult patients over the age of 18 years with a documented AMI 
who underwent CABG or PCI in IALCH within the period of the study and consented to 
participate in the study 
Exclusion Criteria  
Any patient with a terminal illness or a debilitating comorbidity such as incapacitating CVA, 
severe arthritis and other severe diseases, which would preclude moderate physical 
activity. 
Study outcome 
The primary outcome was depression status before and after LSM as assessed using the 
BDI-II questionnaire. The secondary outcome was an improvement in physical function 
and endurance, which is reflected by changes in the level of PA. 
Data analysis 
Data analysis was conducted using SPSS version 25. The demographic, social and clinical 
characteristics of the patients were analysed. Descriptive statistics were used to analyse 
the demographic data, disease characteristics, LSM compliance and depression. The 





using multivariate analysis. The results for all the variables were compared before and 
after initiating LSM. Chi-square-test was used to determine the association between the 
disease characteristics and outcome variables (depression and physical activity) at baseline 
and after LSM, amongst CABG and PCI patients. A general linear model was used to 
evaluate the mean and SD values, and the differences between the group outcomes 
(depression severity and number of subjects with depression) at the baseline, and after 
three months of LSM as a function of the main effect (group differences). The changes in 
the study outcome values (depression and LSM compliance) from baseline to the final visit 
were expressed in both the CABG and PCI groups.  
 
Results 
During recruitment, four (4) patients were excluded due to severe congestive cardiac 
failure (n=3) and debilitating CVA (n=1). 100 patients were recruited (58 males and 42 
females), and of these there were 5 dropouts who did not appear for follow up after the 3 
months of LSM, leaving 95 patients for complete analysis at the end of the study.  
The mean age of the participants was 60.56±4.09 years, with males and females having 
mean ages of 60.73±4.52 vs 60.29±3.64, respectively.  The ages of males and females were 
normally distributed  (p = 0.667) and (p = 0.794) respectively (Shapiro-Wilk score = 0.829). 
The sample comprised mainly Indians (73.0%), the remaining 27.0% about evenly split 
amongst the other race groups. Most of the patients were low-(53.0%) or moderate-
income earners (40.0%). Nine patients (9.0%) had a background history of depression prior 
to the cardiac event and 55 patients (55.0%) reported significant alcohol use. All the 
patients had previously sustained MI and had angiographically confirmed CAD. Most 
patients had multiple CAD risk factors and nearly half of the patients 48 (48.0%) had at 
least one comorbidity, the commonest being chronic kidney disease (43.0%). (Table 1) 
Predictors of depression 
The overall prevalence of depression and depression traits in this sample was 51.0%. The 
main predictors of depression and depression traits were female gender (OR 3.29, 95% CI 
1.51-11.03, p = 0.008), CABG (OR 1.86, 95% CI 1.68-5.77, p = 0.003), heart failure (OR 2.65, 
95% CI 5.87-13.62, p = 0.000), Kidney failure (OR 1.41, 95% CI 1.30-5.23, P = 0.041), atrial 
fibrillation (OR 1.60, 95% CI 1.40-4.77, P = 0.023), low PA (OR 1.97, 95%, CI 11.23- 33.20,   





income (OR 2.21, 95% CI 1.40-2.85, p = 0.000).The level of education (OR 0.60, 95% CI 
0.17-2.14, p = 0.430), age (OR 0.56, 95% CI 0.71-2.00, p = 0.099), COPD (OR 1.30, 95% CI 
0.30-2.98, P = 0.327) as well as the other coronary artery disease risk factors, 
complications  and comorbidities did not show any significant influence on the outcome of 
depression.  (Table 2)    
Effect of the LSM Intervention on the entire sample    
Protocol compliance 
Prior to initiation of LSM program, 5 participants (5.0%) were already physically active, 6 
(6.0%) had changed their diet on their own to a Mediterranean diet, and 11 (11.0%) had 
stopped smoking cigarettes; however only 3 participants (3.0%) were fully compliant with 
LSM ab initio. After 3 months of the LSM program 32 (33.7%) complied fully with the 
protocol. Fifty-eight participants (61.1%) complied with the dietary changes, 72 (75.8%) 
with cigarette smoking cessation, and 38 (40.0%) complied with the minimum accepted 
PA. (Table 3)  
After the LSM intervention the total number of subjects who were physically active 
increased from 5 at baseline to 38 (40.0%) three months later and the number who were 
insufficiently active fell from 95% at baseline to 57 patients (60.0%), (both p = 0.000). The 
PA score improved from 2.81±4.410 at baseline to 11.65±10.600 (p = 0.000) after LSM. 
(Table 3)  
At baseline, 51 participants (51.0%) had depression and depression traits and 49 (49.0%) 
were not clinically depressed (36.0% had mild mood disturbance and 13.0% were 
psychologically normal). Amongst those with depression and depression traits, 18 (18.0%) 
had borderline depression, 23 (23.0%) moderate depression, and 10 (10.0%) severe 
depression at baseline. After the LSM intervention, the number of participants with 
depression and depression traits fell from 51 (51.0%) to 33 (34.7%), p = 0.022 and the 
number without depression and depression traits increased from 49 (49.0%) to 62 (65.3%), 
p = 0.022. (Table 3).    Of the latter group, 11 patients (17.7%) had mild mood disturbance 
and 51(82.3%) had no psychological disturbance at all. Amongst the 33 who had 
depression post LSM, 13 (39.4%) had borderline depression, 13 (39.4%) moderate, and 7 
(21.2%) had severe depression. The mean depression scores fell from (21.91±7.747) at 
baseline to 14.98±9.610 (p = 0.002), indicating a significant reduction in the severity of 





The prevalence and severity of depression and depression traits after the LSM intervention 
were compared in compliant and noncompliant subjects. Both the depression severity and 
the number of subjects with depression were significantly lower in compliant subjects 
(both p= 0.000). Only 1 (3.0%) fully compliant patient had depression out of the total 33 
persons with depression post LSM (p = 0.000). (Table 4)  
Effects of LSM in CABG vs PCI 
Fifty-two patients underwent CABG {m-27, (51.9%); f-25(48.1%)}, and 48 patients had PCI, 
{(m-31, (64.6%); f-17, (35.4%)}. The mean ages in these groups were similar and normally 
distributed  (p = 0.140)  
Physical activity 
Most of the 95 (95.0%) participants were insufficiently active at baseline, with only 5 
(5.0%) being physically active. After LSM the number who reached the desired PA level 
increased from 5 (5.0%) at baseline to 38 (40.0%), (p = 0.000) 3 months later. The PA score 
improved from 2.81±4.410 at baseline to 11.65±10.600 (p = 0.000) after LSM. (Table 3)  
The PA scores were low for both CABG and PCI groups at baseline, though slightly higher 
for PCI (2.15±4.160 and 3.53±4.603 respectively), (p = 0.119). After 12 weeks of the LSM 
regime, more patients undertook PA in the PCI group compared to the CABG group: 27 
(61.1%) vs 15 (33.9%) patients participated often, 7 (73.9%) vs 2 (21.1%) sometimes and 
11 (23.7%) vs 33 (71.3%) rarely, (p = 0.012). The mean PA scores were also higher in the 
PCI compared to the CABG group {(14.16±9.73 vs 9.40±10.94 respectively), (p = 0.024)}. At 
the end of the study 24 (60.0%) subjects in the PCI group and 14 (35.0%) in the CABG 
group reached a satisfactory level of PA based on the GLTE questionnaire cut-off points     
(p = 0.012). 
Depression status  
At baseline, there were fewer PCI subjects with depression compared to the CABG group 
{17 (33.3%) vs 34 (66.3%) respectively, (p = 0.047). The mean depression scores were 
lower in the PCI group compared to CABG {(19.20±7.50) vs (22.10±7.60), (p = 0.049)} 
respectively, indicating more severe depressive symptoms amongst CABG subjects at 
baseline.  (Table 5) 
After 3 months of LSM, the number of participants with depression and depression traits 





traits were seen in the  PCI  compared with the CABG group {8 (23.0%) vs 25 (72.0%)         
(p = 0.001)} respectively. There was a corresponding increase in the number of non-
depressed patients in both groups, with a greater increment amongst the PCI subjects {37 
(56.7%) vs 25 (38.3%) (p = 0.001)}.  The mean depression scores followed the same 
pattern, with a greater point score reduction in the  PCI compared to CABG (7.90 vs 4.30), 
(p = 0.000) respectively, suggesting that the PCI group derived greater benefit than the  
CABG group from the LSM regime. (Table 5)  
In addition, we found the prevalence of depression and depression traits to be significantly 
lower amongst LSM-compliant subjects post LSM (1 person), compared to 32 subjects in 
partly-compliant subjects (p=0.001). Further analysis revealed that the participants who 
were fully compliant in both CABG vs PCI  groups derived similar benefits in terms of 
reduction in prevalence of depression and depression severity, P=0.191), where 8 CABG vs 
5 PCI patients had depression and depression traits amongst the fully complaint patients 
at baseline respectively (P = 0.125), which reduced to 1 CABG vs no PCI patient with 
depression traits post LSM (P = 0.063). (Table 6)     
 
Discussion 
In this prospective study we evaluated the prevalence of depression and depression traits 
amongst MI patients after revascularisation and analysed the effect LSM on depressive 
symptoms. We found a high prevalence of depression and depression traits (51.0%) 
amongst CAD patients who had sustained MI and undergone revascularisation, with  
Similarly, several previous studies have shown that depression is common amongst MI 
patients, ranging from 10-65%. [1-7]  Most of these studies were conducted in the 
developed countries, but a recent study by Ranjith et al analysed depression amongst MI 
patients in South Africa  and  reported a prevalence of 49.0%. [29]  In addition to 
evaluating the prevalence of depression amongst these patients, we also analysed the 
effects of  LSM on incidence of depression and compared the findings between CABG and 
PCI patients.  We found that LSM significantly reduced both the incidence and severity of 
depression and traits amongst MI patients undergoing revascularisation, with compliant 
PCI vs CABG patients deriving similar benefits. To the best of our knowledge, no previous 





Many factors could have contributed to the high prevalence of depression and depression 
traits in our study, among them being gender, low income, previous history of depression, 
low PA, as well as the presence of complications and other comorbidities. Similar to other 
studies [16,19,29],  we have shown those participants with low income, previous history of 
depression and female gender were more frequently associated with depression. In 
addition, it appears those participants with more severe CAD requiring CABG and the 
sicker patients (those with heart and kidney failure) were more likely to experience 
depressive symptoms. This is in contrast to the study of Pelletier et al which showed that 
disease severity does not influence the outcome of depression in MI patients. [14] 
The high prevalence of depression in our study could also be related to the fact that all our 
subjects had sustained previous MI resulting in compensatory haemodynamic and 
neurohormonal consequences of myocardial damage. Factors such as reduced heart rate 
variability (HRV) caused by autonomic dysregulation  and post-infarction inflammatory and 
neurohormonal changes  are common amongst MI patients and have been shown to 
manifest physically as mental and psychological changes of depression and anxiety.       
[33-38]  Patients undergoing CABG probably generate an even greater inflammatory 
response than PCI subjects since they generally have more severe coronary disease 
affecting all three coronary arteries or the left main coronary artery compared to patients 
selected for PCI who are more likely to have single or two vessel disease. The higher 
prevalence of depression amongst CABG compared to PCI subjects in our study could 
therefore be related to the severity of myocardial injury and the greater burden of 
atherosclerotic disease in CABG participants (frequent triple vessel disease and heart 
failure compared to single and double vessel involvement in the PCI group).  
An important finding in our study was that LSM led to a significant reduction in the 
prevalence of depression from 51.0% pre-LSM to 34.7% after LSM intervention. In 
addition, we recorded a six-point reduction in the mean depression scores post LSM, 
(table 3), indicating reduction in the severity of the depressive symptoms with LSM 
intervention. After LSM, depression was three times more frequent amongst CABG than 
PCI patients, (table 5), suggesting that the PCI group benefited more from the 
antidepressive effect of LSM. We attributed the marked difference in depression scores in 
the PCI compared to the CABG group {7.90 vs 4.30 points reduction respectively,                  
(P= 0.000)}, to early ambulation with better improvement in PA in the PCI group. It is 
noteworthy that PA scores were similarly low for both CABG and PCI groups at baseline    





11.65 after LSM intervention (table 3).  The PCI group attained higher PA scores compared 
to the CABG subjects (P = 0.024) by the end of the study period because of their more 
immediate mobility post revascularisation. (Table 5)   
While the adherence to LSM measures showed improvement in dietary changes and 
cigarette smoking cessation amongst the majority of the participants, only 40.0% complied 
with aerobic exercise recommendations; overall, only one third of subjects adhered fully 
to LSM. Poor compliance with LSM recommendations has been reported in previous 
studies. [54-55]   Similar to these studies, the reasons for non-adherence to LSM measures 
in our study were mainly lack of motivation, bodily discomfort and fear of an adverse 
outcome, though no exercise-related adverse effects were reported amongst the 
participants. Thoracic cage and lower limb discomfort as well as fear of potentially adverse 
outcomes after early ambulation post bypass surgery was another possible factor 
accounting for the lower exercise scores amongst the CABG subjects. It is therefore not 
surprising that twice as many PCI subjects participated in frequent physical activity 
compared to the CABG group. This may explain the higher prevalence and severity of 
depression after LSM amongst the CABG group. This is an important limitation of our study 
which to some extent may have been averted if the interview after the LSM intervention 
had been performed six months after surgery instead of three months. 
Although the prevalence of depression in partly-compliant participants fell after LSM, 
(51.0% at baseline to 33.7% post LSM) there was a marked reduction recorded in LSM 
compliant subjects (51.0% patients at baseline to 1.1% post LSM), (p = 0.001). Also, a 
greater point reduction in depression score was seen for subjects who adhered fully to 
LSM measures, indicating a better reduction in severity of depressive symptoms with LSM 
intervention. (Table 4)   An important finding in our study was that fully compliant CABG and 
PCI patients derived similar benefit from the LSM program, emphasizing the role of 
adherence to LSM in reaping maximum benefit after revascularisation, independent of the 
type of procedure.   
 The reduction in depression achieved in partly compliant participants is probably due to 
modest increments in PA from baseline without which depressive symptoms may have 
persisted over time. This has been highlighted by May et al in their ground-breaking study, 
which showed that depression status may not improve completely after MI and is 
associated with two-fold increased risk of death. [16]    Our findings are consistent with 





[50-53]    In a meta-analysis on mental health treatment and LSM for improving clinical 
outcomes and depression among patients with CAD, Rutledge et al [19]    demonstrated 
that not only did  LSM reduce depression to the same extent as mental health treatment, 
but it was also superior in reducing all-cause mortality risk. In another study Richard VM 
and Carl JL [13],   established that LSM reduces depressive symptoms by 63% and all-cause 
mortality by 73.0%.  
Limitations  
Our study has methodological limitations and challenges. Although subjects were 
prospectively evaluated, the convenience non-random sampling method used in this study 
limits the ability to generalise our findings to all CAD subjects. Only participants 
undergoing revascularisation who were able to participate in the LSM recommendations 
were recruited into the study. Participants recruited were referred by state institutions, so 
that most participants were from the lower income group. Furthermore, the PA levels 
were self-reported and were not objectively verified at follow-up through stress testing. 
However, studies have shown that self-reported activity has significant concordance with 
objectively measured physical activity using actigraphy-assessed PA. [39-40]  
A further important consideration is that the 12-week period after revascularisation might 
have been too short for assessing the response to LSM in CABG patients since the 
operation involved mediastinal surgery and lower limb vein grafts which may have 
required a longer period of physical recovery before full physical activity could be resumed 
compared to PCI subjects who were almost immediately ambulant after their procedure. A 
re-evaluation after six months of LSM would have provided a fairer comparison between 
the two groups. The limited time frame of three months for the LSM intervention in our 
study also does not permit long term inferences to be made from our findings since 
persistence of depression over time has been reported by May et al [16]. Also, a more 
informed assessment of the exercise parameters and incidence of depression would have 
been obtained in subjects matched for ejection fraction and disease severity. A longer 
term randomised controlled study is needed to verify our findings and to relate these 
findings to haemodynamic severity of the underlying disease and adjust for other 
confounding factors such level of income and domestic issues which we have shown to be 
predictors of depression.    
The main strength of our study lies in its prospective evaluation of the effects of LSM on 





into the varying responses of the intervention amongst CABG and PCI participants. The 
findings suggest that LSM changes may be safely implemented without fear of potential 
adverse cardiovascular events. Despite its limitations the study is consistent with previous 
studies showing that LSM improves mental functioning and reduces depression and 
depression traits. [50-53] 
Clinical Implications 
Our findings have important clinical applicability, since they emphasize the relationship 
between mental and physical well-being and suggest a successful outcome particularly in 
participants who are able to adhere fully to LSM guidelines regardless of the mode of 
revascularisation. Lower levels of PA short of the required target also appeared to have 
had some anti-depressive benefits since a modest benefit accrued in those who were 
partly compliant with LSM guidelines. These findings suggest that ongoing emphasis on 
counselling patients to overcome the barriers to engaging in adequate PA such as lack of 
motivation and the fear of adverse outcomes are critical to a successful outcome, 
particularly in CABG subjects. This may well translate into morbidity and mortality benefits 
in participants who fully adhere to LSM recommendations. 
Conclusion  
This study confirms a high prevalence of depressive symptoms in MI subjects undergoing 
coronary revascularisation and showed that participants in the PCI group derived greater 
benefit from lifestyle intervention than the CABG group, probably because of early 
ambulation. Although depression is amenable to intervention by LSM measures, the 
beneficial effect of LSM is mainly seen among LSM compliant subjects. Fully compliant 
subjects derived equal benefit, regardless of the mode of revascularisation, emphasizing 
the importance of counselling to overcome the barriers to full participation in LSM and 
undertaking PA. A long-term randomised study is needed to verify these findings. 
Summary 
Depression is common amongst coronary artery disease (CAD) patients and is associated 
with a reduced quality of life (QOL) in these subjects. This study examined the prevalence 
of depression in 100 subjects undergoing coronary revascularisation and sought to 
determine the effect of LSM on depressive symptoms and whether the mode of 
revascularization [coronary artery bypass graft (CABG) vs percutaneous intervention (PCI)] 





depression characteristics in 100 consecutive participants undergoing coronary 
revascularization and re-evaluated the participants after three months of lifestyle 
intervention using the  Beck Depression Inventory to assess depression and the Goldin 
leisure-time questionnaire to assess the physical activity (PA) component of lifestyle 
modification.  
The prevalence of depression among subjects immediately after coronary 
revascularization was 51.0%. After LSM the incidence of depression fell from 51.0% to 
34.7% (P = 0.022), with fewer PCI subjects having depression compared to CABG {PCI 8 
(24.2%) vs CABG 25 patients (75.8%), p = 0.000}.  The mean depression scores also fell 
from 21.11±7.75 prior to LSM to 14.98±9.61 (p = 0.002), with a greater point score 
reduction in the PCI compared to CABG group (7.90 vs 4.30), (p = 0.000) respectively.  
After LSM, both the incidence of depression and depression scores was significantly lower 
amongst LSM-compliant subjects. An important finding in our study was that fully 
compliant CABG and PCI patients derived similar benefit from the LSM program, 
emphasizing the role of adherence to LSM in reaping maximum benefit after 
revascularisation, independent of the type of procedure.  The main predictors of 
depression were female gender (OR 3.29, 95% CI 1.51-11.03, p=0.008),  CABG (OR 1.86, 
95%  CI 1.68-5.77, p=0.003), heart failure (OR 2.65, 95% CI 5.87-13.62, p=0.000), Kidney 
disease (OR 1.41, 95% CI 1.30-5.23, P= 0.041), atrial fibrillation (OR 1.60, 95% CI 1.40-4.77, 
P=0.023),  low PA (OR 1.97, 95%, CI 11.23- 33.20, P=.000), previous history of depression 
(OR 8.99,95% CI 1.90-7.89, p=0.002)   and low income (OR 2.21, 95% CI 1.40-2.85,  
p=0.000). 
This study confirms a high prevalence of depressive symptoms in MI subjects undergoing 
coronary revascularisation and showed that participants in the PCI group derived greater 
benefit from lifestyle intervention than the CABG group probably related to early 
ambulation after PCI. After LSM, depression and depression traits were significantly less 
common amongst LSM-compliant subjects, regardless of the mode of revascularisation. 
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Coronary Artery Disease (CAD), Coronary artery bypass graft surgery (CABG), 
percutaneous coronary intervention (PCI), Lifestyle modification (LSM), Cardiac 
rehabilitation (CR), Home-based cardiac rehabilitation (HCR), Beck depression inventory-II 
(BEC-II), Goldi leisure time-exercise questionnaire (GLTEQ), physical activity (PA), 
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Table 1: Demographic data and baseline characteristics 
Characteristics  Variables        n=100 (%) 
Gender/ Age (mean+SD) Male               60.73±4.52  58.0 
Female           60.29±3.64 42.0 




Yearly income Low 53.0 
High/moderate 47.0 
Educational level Primary school 11.0 
High school/Tertiary 89.0 
Depression history Yes  9.0 
No 91.0 
CAD diagnosis STEMI*  89.0 
NSTEMI# 11.0 





Sedentary lifestyle 76.0 
Family history of CAD 53.0 
Cigarette smoking 70.0 
Obesity 45.0 
Comorbidities Kidney disease 43.0 
Arthritis 19.0 
Other vascular diseases** 17.0 
Hypothyroidism  7.0 
COPD  4.0 
Other comorbidities ## 10.0 
Complications Heart failure 28.0 
Atrial fibrillation 8.0 
* STEMI: ST elevation myocardial infarction 
# NSTEMI: Non-ST elevation myocardial infarction 
**other vascular disease: 11 peripheral vascular disease, 6 CVA 
##other comorbidities: 2 valvular heart diseases, 2 RVD, 4 psoriasis, 2 SLE 










Table 2: Predictors of depression 
 Characteristics Variables Depressed 
n=51 (%) 
No depression     
n =49(%) 
Total     OR (95% CI) p- value 
 Age (years)  (mean±SD)   71±1.122 71±2.34  0.56 (0.71-2.00) 0.099 
Gender Male 23 (45.1) 35 (71.4) 58  
3.29 (1.51-11.03) 
 
0.008 Female            28 (54.9) 14 (28.6) 42 
 
Income 
Low 42 (82.4) 11 (22.4) 53  
2.21 (1.40-2.85) 
 
0.000 High 9 (17.6) 38 (77.6) 47 
ACS intervention PCI 17 (33.3) 31(63.3) 48  
1.86 (1.68- 5.77)  
 
0.003 CABG 34 (66.7) 18 (36.7) 52 
Depression history No 42 (82.35) 49 (100) 91  
8.99 (1.90-7.89) 
 
0.002 Yes   9 (17.65)   0 (0) 9 
Educational level Low   5 (9.8)   6 (12.2) 11   
0.60 (0.17-2.14) 
 
0.430 High 46 (90.2) 43 (87.8) 89 
 
Physical activity 
Low 50 (53.0) 45 (47.0) 95  
1.97(1.23- 33.20) 
 
0.000 High 1 (20.0) 4 (80.0) 5 
CAD risk factors 
 
c cholesterol 43 (84.3) 41 (83.7) 84 1.05 (0.36-3.06) 0.930 
Diabetes 43 (84.3) 35 (71.4) 78 1.75 (0.79-5.70) 0.120 
Hypertension 43 (84.3) 35 (71.4) 78 1.77 (0.80-4.50) 0.120 
Sedentary life 39 (76.5) 37 (75.5) 76 1.05 (0.42-2.64) 0.910 
Cigarette smoking 40 (78.4) 30 (61.2) 70 0.30 (0.80-1.60) 0.061 
Obesity 27 (52.9) 24 (47.1) 51 0.95 (0.90-7.21) 0.567 
Comorbidities and 
complications 
Kidney disease 27 (52.9) 16 (32.7) 43 1.41 (1.30-5.23) 0.041 
Heart failure 24 (47.1) 4 (8.2) 28 2.65 (5.87-13.62) 0.000 
Arthritis 11 (21.6) 8 (16.3) 19 1.41 (0.51-3.87) 0.504 
Other vascular ** 10 (19.6) 7 (14.3) 17 1.16 (0.71-4.21) 0.479 
Thyroid disease   4 (7.8) 5 (10.2) 9 0.75 (0.19-2.97) 0.679 
Atrial fibrillation   1 (2.0) 7 (14.3) 8 1.60 (1.40-4.77) 0.023 
COPD   3 (5.9) 1 (2.0) 4 1.30 (0.30-2.98)  0.327 
OR: odds ratio, ACS: Acute coronary syndrome; COPD: chronic obstructive pulmonary disease.  
PCI: percutaneous coronary intervention; CABG: Coronary artery bypass graft surgery 
 










Table 3: Effects of LSM on lifestyle parameters and depression 
Variables Pre LSM     
n=100 (%) 





5(5.0) 38(40.0) 0.0001 
Cessation of 
smoking 
11(11.0) 72(75.8) 0.0001 
Diet 
modification 
6(6.0) 58(61.1) 0.0038 
Total LSM 
compliance 










21.11±7.75 14.98±9.61 0.0019 
Depression 51(51.0) 33(34.7) 0.0216 
No depression 49(49.0) 62(65.3) 0.0216 
* At the beginning 100 patients were recruited, but there were five dropouts during the study, leaving 95 
participants for analysis after the LSM intervention.        
 Lifestyle modification yielded improved aerobic scores and a four-point reduction in the depression scores 

















Table 4: Effects of LSM in compliant and non-compliant groups   
 
LSM: Lifestyle modification yielded improved exercise scores and a fall in                                                          


































Depression score        
post LSM 
(mean±std) 
10.20±7.00 16.70±10.30 0.0001 
Depression (n)   1 (2.9%) 32 (92.1%) 0.0001 





Table 5: Effect of LSM : CABG vs  PCI  group 
 
LSM: Lifestyle modification; PCI: percutaneous coronary intervention 
CABG: Coronary artery bypass graft surgery 
LSM was more effective after PCI, with lower depression scores and reduced incidence                                                                                                                                                                            
of depression, as well as improved aerobic and dietary compliance in PCI subjects 
*The lower participant numbers reflect the changes recorded in 95 participants after LSM because there were 







                                         
  
Lifestyle parameters 
CABG n=52* PCI n=48* p-value 
n (%)  n (%) 
Aerobic exercise 
score 
Pre LSM 2.15±4.16 3.53±4.60 0.119 
Post LSM 9.40±10.94 14.16±9.73  0.024 
Aerobic exercise 
compliance 
Pre LSM   2 (40)   3 (60) 0.715 
Post LSM 14 (35.0) 24 (60.0) 0.012 
Dietary measures 
compliance  
Pre LSM 3 (50.0) 3 (50.0) 0.200 
Post LSM  30 (49.1) 28 (45.9) 0.200 
Smoking cessation 
compliance  
Pre LSM 6 (54.5) 5 (45.5) 0.590 
Post LSM 40 (52.8) 32 (42.2) 0.593 
Total LSM 
compliance 
Pre LSM 1 (33.3) 2 (66.7) 0.217 
Post LSM  12 (35.6) 20 (59.4) 0.022 
Depression score Pre LSM 22.10±7.60 19.20±7.50  0.049 
Post LSM* 17.80±10.60 11.30±6.60   0.000 
Depression status 
Pre LSM 
Depressed 34 (66.7) 17 (33.3) 0.047 
0.047 Not depressed 18 (36.7) 31 (63.3) 
Depression status 
Post LSM* 
Depressed 25 (72.0)   8 (23.0) 0.001 





Table 6: Effects of LSM: compliant CABG vs compliant PCI groups  










Total LSM compliance 12(35.6) 20(59.4) 1.70 (2.30-5.67)   0.022 
Aerobic exercise score 
(mean±std) 
14.96 18.91 1.10 (1.31-4.82)   0.049 
Depression score       
(mean±std) 
10.81 7.62 1.21 (1.12-3.92)   0.046   
Depression pre LSM 0.125   (3.97-0.89)0.91 (40.0)8® (41.7)5٭ 
Depression post LSM 1 (7.9) 0(0.0)  0.96(0.80-3.30)   0.063 
No depression pre LSM 7 (58.3) 12(60.0) 1.0(0.91-2.94)   0.097 
No depression post LSM ©11(87.1) ӿ20 (95.0) 1.19(0.75-4.10)   0.113 
 The prevalence of  depression fell from 5 persons  pre LSM to 1 post LSM (80.0% reduction) amongst  fully٭
compliant CABG group.   
®There was no person with depression post LSM from the initial  8 depressed fully compliant PCI subject 
(100.0% reduction) amongst fully compliant PCI group.  
The difference in reduction between fully compliant CABG and PCI was 80.0% vs 100.% (OR 1.10, CI 0.98-
4.23,P= 0.191), which was not statistically significant. 
© The number of patients with no depression increased from 7 persons  pre-LSM  to 11 post LSM in fully 
compliant CABG  group (57.1%). 
ӿ There was 66.7% increment in the number of subjects with no depression post LSM, from  the initial 12 to 20 
patients  amongst fully compliant PCI group.  
The difference in increment between the fully compliant CABG and PCI  was 57.1% vs 66.7% (OR 0.91, CI 0.97-














CHAPTER 3: Appendices 
 
Appendix I: Study protocol  
 
Effect of lifestyle modification on depression in coronary artery disease 
patients after revascularization 
 
Problem Statement: 
The prevalence of noncommunicable diseases of lifestyle is increasing in developing countries, 
including South Africa. This has resulted in worsening morbidity, mortality and psychosocial 
adverse outcome of coronary artery disease (CAD) in contrast to developed countries, where 
modern therapies and lifestyle modification (LSM) has been shown to reduce morbidity, 
mortality and improve quality of life  (QOL), particularly  reduction in the prevalence of 
depression. The purpose of this study is to evaluate prevalence of depression amongst CAD 
patients after revascularization and analyze the effect of LSM on depression and QOL.  
 
Research Questions: 
 How common is depression amongst CAD after revascularization? 
 What is the effect of LSM on depression and QOL after revascularization? 
 Do confounders like comorbidity, type of revascularization, income status, previous history of 
depression and gender affect depression after revascularization? 
 
Hypothesis: 
Lifestyle modification reduces prevalence of depression and improves QOL and after 
myocardial infarction (MI) 
 
Aim:  
To evaluate the prevalence of depression and analyse the effect of LSM on depression and 
QOL amongst MI patients after revascularization 
 
Objectives:  
1. To determine the baseline clinical profile (signs and symptoms) of the patients’ pre-LSM and 
post LSM period. 
2. To determine the status of prevalence of depression at baseline (three weeks/more)   





4.  To determine the effects LSM on depression and QOL amongst the patients pre and post LSM 
5. To determine the effects of confounding factors such as comorbidity, type of 
revascularization, income status, previous history of depression, physical activity profile and 




Studies have shown that depression is common amongst CAD patient with a prevalence 
varying from 10% to 65%. [1-6]   Depression is thought to be a risk factor for CAD as well a 
poor prognostic factor [3-6] and is associated with a worse adverse outcome and reduced 
health-related quality of life. [7-10]   It is well established that CAD with depression have 
increased chances for MI recurrence and are more risk of death. [7-10]   In the Baltimore 
cohort of the Epidemiologic Catchments Area study follow-up, major depression significantly 
increased the risk of acute myocardial infarction (OR 4.54, 95% CI 1.65-12.44). [11]                          
A systemic review by the American Heart Association also found that depressed myocardial 
infarction patients had a significant increase in all-cause mortality, cardiac mortality and 
chances for recurrence, compared to non-depressed patients. [12]   
 
Although prevalence of CAD is increasing globally, morbidity and mortality are noticed to be 
reducing in advanced countries. [13-19]    In contrast, morbidity and mortality is increasing in 
developing countries, with more CAD patients having difficulties resuming normal lifestyle 
patterns, including return to work and participation in social and recreational activities. These 
difficulties result in a poorer QOL and depression in these patients. The decrease in morbidity 
and mortality and improvement in QOL reported in developing nations has been attributed 
principally to the introduction of better therapies as well as LSM which shows promising 
results in primary and secondary prevention of CAD, reduction in major adverse cardiac event 
(MACE) as well as improvement in QOL and  depressive symptoms. [13-19] 
 
Lifestyle modification regime is a standardized program of exercises, health education, and 
behavioral changes that aim to help CAD patients live a normal or near-normal life. [20-22]    It 
involves training in aerobic exercises and health education, ranging from healthy eating, stress 
management and cessation of smoking. [20-22]    For LSM to be successful, compliance with 
the regimen needs to be ensured. Compliance can be gauged using an established 





5 times a week. Cessation of cigarette smoking and Mediterranean type of diet, which include 
a large portion of vegetables and fruits, fish, and less red meat/saturated fatty acid. [20-22] 
 
Many studies have highlighted the beneficial effects of LSM after MI. It enhances early 
recovery, reduces subsequent fatal MI, increases QOL, as well as decreases mortality from 
CAD. [23-32] The tremendous improvement noticed is believed to be due to generalized 
reduction in modifiable cardiac risk factors, and improvement in the patient's life 
physiologically, physically, and psychologically. [23-32] This improvement is believed to 
account for the increase in QOL and decline in the mortality rate observed in many developed 
countries.  [23-32]. Due to its benefits, several international guidelines {American heart 
association (AHA), Australian Cardiovascular Health and Rehabilitation Association (ACRA), 
and European Society of Cardiology (ESC)} have recommended LSM as an important 
component of comprehensive care to cardiovascular patients [33-35]. 
 
A multicentered study by Carl J et al compared benefit of LSM among elderly (>65 years) and 
younger patients (<65 years) cardiac patients post-MI. Both groups were statistically similar 
regarding baseline levels of total cholesterol, LDL cholesterol, behavioral characteristics, and 
parameters of QOL. The patients underwent a monitored LSM regimen under cardiac 
rehabilitation exercise programs, which started at 2 to 6 weeks after ACS and 4 to 8 weeks 
after bypass surgery and lasted approximately 3 to 4 months. The program included exercise 
sessions and educational programs on diets and other lifestyle changes. The result revealed 
that elderly patients showed very significant improvement in exercise capacity (+43%, p< 
0.0001) after cardiac rehabilitation, which was statistically greater than the improvement 
(+32%; p <0.0001) noted in younger patients (p ~0.01). Improvement in all other parameters 
were statistically similar in both groups. Behavioral characteristics and QOL measures such as 
anxiety (p <0.01), depression (p <0.01), somatization (p <0.0001) as well total quality of life 
(all p ~0.0001) improved significantly after cardiac rehabilitation and exercise training in both 
groups. Mental health score improved more in the elderly (+5% vs +2%; p = 0.05) than in 
younger patients, but all other improvements in behavioral characteristics and QOL 
parameters were statistically similar in both groups. [36].  
 
Amongst the studies that analyzed incidence of depression after MI was the “Depression after 
First Hospital Admission for Acute Coronary Syndrome : A Study of Time of Onset and Impact 





whether the timing of onset of depression influenced long term survival. The ACS patients 
(cases) were identified through the National Patient Register, and a comparable reference 
population sample (control) was matched on 1:1 basis. Both samples were followed for 
depression and mortality outcomes from the beginning of the study until the end of follow-
up (2 years for depression and 12 years for mortality). The results showed that 19,520 (20.0%) 
out 97,793 ACS patients recruited developed depression within 2 years of follow up, while in 
the reference population 14,386 persons (14.7%) developed depression. Higher rates of 
depression were seen in single persons, people with a basic education, and people with 
previous depression or other disease comorbidity.  Although the depression rate was higher 
in women than men this finding was not significant. At the end of 12 years follow-up, 39,523 
(40.4%) ACS patients and 27,931 (28.6%) members of the reference population died. Mortality 
rate was higher amongst depressed patients compared to those without depression in both 
the ACS patients and the reference population. This study concluded that depression is 
common in ACS patients and it is associated with increased mortality independent of its time 
of onset. [37] 
 
In another study conducted by Antonakoudis H. et al, conducted in the department of 
Cardiology, Asclepeion Hospital, Athens, Greece, in the year 2005/2006, a total of 110 cardiac 
patients were recruited and followed up for two (2) months. They were divided into three (3) 
groups, namely A, B and C. Group A consisted of 60 post-AMI patients participating in a LSM 
under CR program, group B Consisted of 40 post-AMI patients not participating in any LSM 
program, while the control group C consisted of 10 apparently healthy people. QOL was 
evaluated by the Velasco-Del Barrio questionnaire, a QOL evaluation questionnaire consisting 
of 9 items (health, sleep, and rest, emotional behavior, concerns for the future, mobility, social 
interaction, alertness behavior, communication, work, and leisure time). A five (5) point scale 
(1= all the time, 5= none of the time) and a special (1 to 8) coefficient for each parameter were 
used for the evaluation of each parameter. The highest score of 220 indicates the poorest 
QOL. The result of the study showed that the LSM group A patients had better QOL as 
compared to non-LSM group B (94±3 vs 114±3, p<0.001), and slightly worse QOL compared to 
the control Group C (94±4 vs 69±3, p<0.01). Significant differences were found among LSM 
Group A and non-LSM group B patients regarding the important QOL parameters evaluated 
such as angina, dyspnea, depression (17±6.8 vs 22±6.5, p<0.001) and social behavior (21±4.2 
vs 23±5.5, p<0.0001). They concluded that LSM in form of CR program significantly improves 





In conclusion, while a beneficial effect of LSM in improving QOL and depressive symptoms 
have been reported in several studies, there is minimal information regarding that in 
developing countries including South Africa. 
 
Rationale 
With rapid urbanization and westernization in terms of diet, physical inactivity and smoking 
in SA, there is documented increase in CAD and its complications, particularly depression. 
Studies reported that LSM has shown promising results in primary and secondary prevention 
against CAD, with improvement in QOL and reduction in psychosocial complications. However 
little data exist in developing countries regarding the effect of LSM on QOL and depression 
after revascularization. This study aims to analyze that. The information to be generated 





The study is prospective in nature, in which a cohort of MI patients would be followed 
longitudinally to determine the prevalence of depression and effect of LSM and prevalence of 
depression among MI patients who underwent revascularization (CABG or PCI). 
 
Setting 
The research will be sited at IALCH Cardiology OPD clinic. Approximately 25 CABGs are done 
per month. These patients are followed up till six weeks’ post-surgery on an out-patient basis 
by the surgeon. After six weeks, they are referred to Cardiology unit follow-up at 6 months, 
then yearly till three years’ post-surgery. 
 
Methods 
The risk factor profile, depression characteristics and lifestyle changes of 100 consecutive 
participants undergoing coronary revascularization in the department of Cardiology IALCH 
would be obtained at the beginning of the study. The Demographic and other clinical data   
would be obtained from patient's file. The Beck Depression Inventory would be used to assess 
depression and the Goldin leisure-time questionnaire to assess physical activity (PA). The 







The study population will be all adult patients who have underwent CABG and or PCI in the 
Departments of Cardiology of IALCH with in the time of the study and are willing to participate 
in the research.   
 
Inclusion criteria 
Adult Subjects will be recruited who have had documented AMI on coronary angiography and 
underwent CABG and or PCI during the time of the study.  
 
Exclusion Criteria  
Any patient with other major debilitating comorbidity, like advanced cancer, debilitating CVA, 
Severe arthritis and other severe incapacitating disease, which would preclude physical 
activity as a parameter of LSM. 
 
Sampling 
Convenient non-random sampling will be used. All consenting subjects who have either 
underwent PCI or CABG after AMI presenting to Cardiology clinic will be consecutively 
enrolled. The Sample size was calculated to be 150, based on Kwazulu-Natal (KZN) 2016 
population estimate of 11, 079, 717 people [Stat SA 2016] and CAD prevalence of 5% [KZN 
burden of disease]. But almost all unstable angina and many of the MI patient do not undergo 
revascularization but treated medically, thus our sample size reduced to 100 since we are only 
to study the patient that undergo revascularization.  
 
Statistical analysis 
Recording and analysis 
From the data generated, patients are to be stratified by racial group, age, gender, and mode 
of therapy (CABG vs PCI) for analysis. Demographic and clinical data of patients at the time of 
admission and after LSM intervention would be obtained from patients’ file. Descriptive data 
will be expressed as mean ±SD. Categorical variables would be reported by frequency and 
percentage. Continuous variables are to be reported as medians and 25th and 75th 
percentiles (inter quartile range, IQR) as per their distribution. FS-36 QOL questionnaire would 
be used to inquire about changes in QOL pre- and post- LSM. From the data generated, 
patients are to be stratified by mode of revascularization (CABG vs PCI) for analysis. Baseline 





test. Baseline and repeat evaluation at three months will be compared in each group by a 
paired t test, and the changes in data between groups to be analysed with a 2 factor (data 
pre- and post-intervention, and mode of therapy) repeated measures of analysis of the 
variance with repeated measures in a 1 factor (data before and after) test. Multivariate 
analysis/logistic regression will be used to determine predictors of QOL changes post 
revascularization. A p value < 0.05 will be considered significant. SPSS statistical software 
would be used for data analysis. 
 
Limitations 
The study will be limited to public sector patients at IALCH. This may have an impact on the 
generalizability of the results. Another major limitation will be the non-random sampling 
method, which will limit the strength of the study. 
 
Potential Impact of the study 
Routine blood tests for HbA1c and lipid profile will be done. This is important for it helps to 
indicate changes in CAD risk factor and whether treatment targets have been reached in the 
patients’ management or not. This research would be beneficial in that it would assist in 
delineating prevalence of depression and effect lifestyle modification intervention on 
depression. It will improve knowledge and high light the importance of LSM in management 
of MI patients. Feedback will be given to the units involved on the findings of the study. 
Research findings will be presented at congresses and published in journals. 
 
Ethical issue 
Approval will be obtained from the Biomedical Research Ethics Committee (BREC) of the 
University of KwaZulu-Natal, as well as the Chief Executive Officer (CEO) of the IALCH before 
starting data collection. 
 
Informed written consent will be obtained from participants. All questionnaires should be in 
English and will be administered with self of researcher or research assistant. 
 
The Head of department of Cardiology and Cardiothoracic surgery have given permission to 
conduct this study. The patients involved in the research will be at minimal risk with regards 





sex, and age. No recorded material neither video footage nor pictures will be taken. Only 
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